MabVax Therapeutics' Secondary Market Round

MabVax Therapeutics raised a round of funding on January 02, 2012. Investors include Biomark Capital.

MabVax Therapeutics is a clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address unmet medical needs in the treatment of cancer. MabVax is cr…

Articles about MabVax Therapeutics' Secondary Market Round: